3-42590932-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001370300.1(SS18L2):c.35G>C(p.Gly12Ala) variant causes a missense change. The variant allele was found at a frequency of 0.000013 in 1,305,762 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001370300.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SS18L2 | NM_001370300.1 | c.35G>C | p.Gly12Ala | missense_variant | Exon 1 of 3 | ENST00000011691.6 | NP_001357229.1 | |
SS18L2 | NM_016305.4 | c.35G>C | p.Gly12Ala | missense_variant | Exon 2 of 4 | NP_057389.1 | ||
SEC22C | NM_001201572.2 | c.-28+10028C>G | intron_variant | Intron 1 of 6 | NP_001188501.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SS18L2 | ENST00000011691.6 | c.35G>C | p.Gly12Ala | missense_variant | Exon 1 of 3 | 1 | NM_001370300.1 | ENSP00000011691.4 | ||
SS18L2 | ENST00000447630.5 | c.35G>C | p.Gly12Ala | missense_variant | Exon 2 of 4 | 2 | ENSP00000401115.1 | |||
SEC22C | ENST00000417572.5 | c.-28+10028C>G | intron_variant | Intron 1 of 6 | 3 | ENSP00000407564.1 | ||||
SEC22C | ENST00000450981.5 | c.-179-3370C>G | intron_variant | Intron 1 of 4 | 3 | ENSP00000397170.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.00000798 AC: 2AN: 250608Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135558
GnomAD4 exome AF: 0.0000130 AC: 17AN: 1305762Hom.: 0 Cov.: 34 AF XY: 0.0000123 AC XY: 8AN XY: 648380
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.35G>C (p.G12A) alteration is located in exon 1 (coding exon 1) of the SS18L2 gene. This alteration results from a G to C substitution at nucleotide position 35, causing the glycine (G) at amino acid position 12 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at